Heron Therapeutics, Inc. (HRTX)

Last Closing Price: 0.27 (2026-11-18)

Debt to Capital Ratio (Quarterly)

Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)

Heron Therapeutics, Inc. (HRTX) had Debt to Capital Ratio of 0.96 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$35.25M
$-5.01M
$8.96M
$26.29M
$36.92M
$-1.67M
$-3.34M
$-5.01M
$-5.01M
$-5.01M
$-5.01M
$-5.01M
$-5.01M
$-1.67M
$-1.10M
190.92M
190.92M
$-0.03
$-0.03
Balance Sheet Financials
$209.11M
$11.08M
$21.34M
$230.45M
$89.85M
$126.01M
$135.68M
$225.53M
$3.87M
$4.92M
$4.92M
189.91M
Cash Flow Statement Financials
$-4.55M
$5.89M
$-18.39M
$28.65M
$11.60M
$-17.05M
$9.24M
--
--
Fundamental Metrics & Ratios
2.33
--
--
Debt to Capital Ratio
0.96
25.63
74.59%
-4.73%
-4.73%
--
-14.20%
-14.20%
$-5.18M
--
--
--
0.15
0.10
0.41
221.45
-129.49%
-101.83%
-2.17%
-3.82%
$0.03
$-0.03
$-0.02